Download Breaking News - Southern Health NHS Foundation Trust

October 2014
The latest update from the medicines management committees and the medicines management team:
http://www.southernhealth.nhs.uk/knowledge/medicines-management
Clinical news ……
Pipothiazine palmitate (Piportil Depot®) is being discontinued from the end of March 2015. SanofiAventis advise that piportil is being discontinued from the end of March 2015 due to problems sourcing
one of the ingredients. Please review all patients currently receiving piportil and consider a suitable
alternative.
Nitrofurantoin is now contraindicated in patients with an estimated glomerular filtration rate (eGFR)
of less than 45ml/min/1.73m2 (this is a reduction from the previous rate of 60).
Denosumab has been associated with a risk of osteonecrosis of the jaw (ONJ) and with a risk of
hypocalcaemia. Before starting denosumab treatment, a dental examination is recommended.
Visit the MHRA drug safety updates for further information:
http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/index.htm
A new green book chapter on human papillomarvirus (HPV) – chapter 18a, has been published by
Public Health England visit www.gov.uk for further information
New from NICE …………….
Clinical Guidelines (CG)
Multiple sclerosis CG 186
Acute heart failure CG 187
Dyspepsia and gastro-oesophageal reflux disease CG 184
Bipolar disorder CG 185
Quality Standards (QS)
Nocturnal enuresis in children and young people QS 70
Intravenous fluid therapy in adults in hospital QS 66
Visit www.nice.org.uk for details
New from the British Association for Psychopharmacology (BAP)
Evidence based guidelines for the pharmacological treatment of anxiety disorders 2014
Evidence based guidelines for the pharmacological treatment of attention deficit hyperactivity disorder
2014
Visit www.bap.org.uk for details
Formulary news…………….
Lurasidone will remain non-formulary. Lurasidone a new second generation antipsychotic has
recently been evaluated by the mental health guidelines and formulary committee. The conclusion from
the committee was there is currently insufficient long term safety and efficacy date to recommend its
use. Other antipsychotics with similar properties are also already available. Lurasidone will remain nonformulary. The decision will be reviewed when new evidence becomes available.
What’s new ……
David Jones- Chief Pharmacist
Stephen Bleakley – Deputy Chief Pharmacist
1
October 2014
October 2014
Aripiprazole Long Acting Injection Guidelines. Are now available on the trust website. This includes
guidance on how to switch from other antipsychotics. Please note consultants psychiatrists wishing to
use the aripiprazole long acting are requested to complete the application form for approval found at:
http://www.southernhealth.nhs.uk/knowledge/medicines-management/forms/?assetdet1450445=78951
Self-administration guidelines: (SH CP 168) has recently been updated and now covers trust wide
services. Wards are requested to check they are working to the new guidelines.
The procedure on checking and filling a compliance aid (SH CP 170) has recently been updated
and is now available on the trust website,
Oral Anticoagulants online e-learning. MRHA have just launched an online, e-learning module which
outlines the key risks of these widely prescribed medicines. To access the learning module, you will
need to create an account. Visit
http://www.mhra.gov.uk/ConferencesLearningCentre/LearningCentre/Medicineslearningmodules/Oralant
icoagulants/index.htm for more information.
All medicines management policies, guidelines or forms can be found at:
http://www.southernhealth.nhs.uk/knowledge/medicines-management/
Audit updates
Waste audit results. The medicines management team recently undertook a medicines waste audit
across in-patient units. Please can all in-patient units ensure they have controlled drug denaturing kits
available, a list of cytotoxic and cytostatic medicines attached to the purple waste bin and that the blue
medicines waste bin is locked away.
Omission audit results. A recent omission audit looking at how nursing staff sign prescription charts
returned the lowest rate of blanks yet recorded. Looking at over 5000 individual drugs administered
1.2% were not signed for and left blank. This is an improvement from 1.7% in 2013 and 9.2% in 2012.
Reminder……
Patient Group Directions (PGDs). Please note that only authorised PGDs (approved by the medicines
committee and the trust executives) and in date PGDs should be in use. Trust approved PGDs are found
at: http://www.southernhealth.nhs.uk/knowledge/medicines-management/pgds/
Coming soon……………
Non-medical prescribing conference. Places are still available for the trust wide non-medical
prescribing conference (21st November, East Horton Golf Club).
CPD update: Pharmacology refresher training. Update your pharmacology basics (including drug
interactions, absorption, metabolism and elimination). Places are still available (17th November,
Moorgreen Hospital)
CPD update: Clozapine update. Come to an update on everything you need to know about clozapine
on 3rd December, Antelope House, Southampton.
For information visit the lead training website
The trust wide medicines policy (MCAPP – SH CP 1) is being updated. All comments / suggestion are
most welcome. Please send to [email protected])
Resources
The new BNF is out. BNF 68 Sept – March 2015. Hard copies will be distributed to medical staff over
the next month via the medicines management team. Old versions can be handed back to our team for
re-use during training. Please note the BNF is also available at: www.bnf.org and via a free app (you will
need an NHS Athens password to access)
Feel free to email [email protected] if you would like to make any comments about our breaking news
bulletin or recommend future news items.
Please email [email protected] if you would like to be added to the email distribution list for breaking news.
David Jones- Chief Pharmacist
Stephen Bleakley – Deputy Chief Pharmacist
2
October 2014